Gomisin A modulates aging progress via mitochondrial biogenesis in human diploid fibroblast cells

Clin Exp Pharmacol Physiol. 2018 Jun;45(6):547-555. doi: 10.1111/1440-1681.12914. Epub 2018 Feb 13.

Abstract

Gomisin A from the fruit of Schisandra chinensis has many pharmacological properties, including hepato-protective, anti-diabetic, and anti-oxidative stress. However, the potential benefit of gomisin A is still not well understood, especially in aging progression. Therefore, the aim of this study was to clarify whether the promotion of mitochondrial biogenesis and autophagy of gomisin A affects anti-aging progression, and its mechanism. Intermediate (PD32) human diploid fibroblast (HDF) cells were brought to stress-induced premature senescence (SIPS) using hydrogen peroxide. Gomisin A inhibited reactive oxygen species production even in the SIPS-HDF cells. Gomisin A was also able to attenuate the activity of senescence-associated β-galactosidase and the production of pro-inflammatory molecules in the SIPS as well as aged HDF cells. The antioxidant activity of gomisin A was determined by recovering the Cu/Zn, Mn-SOD, and HO-1 expression in the SIPS-HDF cells. In mechanistic aspect, gomisin A inhibited the mitogen-activated protein kinase pathway and the translocation of nuclear factor kappa B to the nucleus. In addition, gomisin A promoted the autophagy and mitochondrial biogenesis factors through the translocation of nuclear factor erythroid 2-related factor-2, and inhibited aging progression in the SIPS-HDF cells. In summary, the enhanced properties of mitochondrial biogenesis and autophagy of gomisin A has a benefit to control age-related molecules against SIPS-induced chronic oxidative stress, and gomisin A may be a potential therapeutic compound for the enhancement of intracellular homeostasis to aging progression.

Keywords: Schisandra chinensis; anti-inflammation; antioxidant; autophagy; homeostasis; stress-induced premature senescence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / drug effects*
  • Aging / metabolism
  • Anti-Inflammatory Agents / pharmacology
  • Antioxidants / pharmacology
  • Autophagy / drug effects
  • Cell Survival / drug effects
  • Cyclooctanes / pharmacology*
  • Dioxoles / pharmacology*
  • Diploidy*
  • Down-Regulation / drug effects
  • Fibroblasts / cytology*
  • Fibroblasts / drug effects*
  • Fibroblasts / metabolism
  • Humans
  • Lignans / pharmacology*
  • MAP Kinase Signaling System / drug effects
  • NF-E2-Related Factor 2 / metabolism
  • NF-kappa B / metabolism
  • Organelle Biogenesis*
  • Oxidative Stress / drug effects
  • Protein Transport / drug effects
  • Reactive Oxygen Species / metabolism

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Cyclooctanes
  • Dioxoles
  • Lignans
  • NF-E2-Related Factor 2
  • NF-kappa B
  • NFE2L2 protein, human
  • Reactive Oxygen Species
  • schizandrol B